Skip to main content
Fig. 2 | Inflammation and Regeneration

Fig. 2

From: Add-on multiple submucosal injections of the RNA oligonucleotide GUT-1 to anti-TNF antibody treatment in patients with moderate-to-severe ulcerative colitis: an open-label, proof-of concept study

Fig. 2

Induction of endoscopic improvement by add-on GUT-1. A Rates of endoscopic improvement at baseline (BL), week 2, 4 and 6. B Endoscopic findings of the heaviest lesion at baseline (BL; week 0) and the same lesion at weeks 2, 4 and 6 in 3 corticosteroid-dependent UC patients are presented (case 1, 4 and 5)

Back to article page